Clinical Trials Browser

Phase 2 × Unknown × Ramucirumab × Clear all

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT04632459 2022-03-11

Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT03966118 2019-06-03

AIO-STO-0218

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms